International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Colloidosomes

Colloidosomes


As per available reports about 43 Relevant Journals, 43 Conferences, 11 Workshops are presently dedicated exclusively to colloidosomes and about 156 articles are being published on colloidosomes. 

Colloidosomes are hollow spherical structures that are formed by the assembly of colloidal particles at the interfaces of two immiscible liquids. As a result the particles are arranged in a shell that is inherently porous. The assembly of colloidal particles at liquid interfaces is used in various applications. Moreover, it is a promising technique for the synthesis of novel materials3 and has recently led to the development of colloidosomes.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

The use of thermally responsive polymer surfactants implies that new thermally responsive colloidosome dispersions could be prepared and this will be examined in future work. During the last two decades, technologies to ensure colloidosomes release have been developed. Significant progress has been made towards achieving colloidal systems that can effectively treat diseases with non-constant dosing therapies. However, there is much work that needs to be carefully demonstrated for the developing colloidal systems.

Colloidosomes can address a wide variety of encapsulation needs in addition to nutrient and drug delivery. One important possibility is immunoisolation of living cells by encapsulation in colloidosomes; they would provide a rigid scaffold that supports the living cell while simultaneously protecting it from the immune system and allowing free diffusion of gases and nutrients. The required 25-nm pore diameter would be achieved using colloidal spheres of 170-nm diameter, well within the range of sizes of particles known to adsorb strongly onto droplets.

Colloidosomes encapsulating cells could also have advantageous properties as bioreactors. Furthermore, a superstructure of colloidosomes may form templates for tissue growth by providing a protected environment that has a useful three-dimensional architecture and allows rapid permeation of small macromolecules. In preliminary experiments, we successfully encapsulated living fibroblast cells and maintained their viability for several hours using particle-coated water droplets in decalin oil. In many cases, the cells adhered to the solid surfaces, suggesting that colloidosomes can be fabricated as rigid porous superstructures to enhance the viability of the cells. Plant protoplast cells are known to survive and grow even after 25 days in contact with oxygen-perfused perfluorodecalin oil, suggesting that the exterior oil phase might not damage the cells during a brief exposure. The key to cell viability is the suitability of the colloidosomes surface; other methods of locking the particles together, such as avidin-biotin binding, may make the colloidosomes even more biocompatible.

Colloidosomes successfully meet many of the key requirements for encapsulation: Emulsification provides a simple means of producing capsules from a wide variety of fluids and with controlled sizes ranging from submicrometer to several millimetres. Furthermore, because the internal and external fluids remain completely separate until the final step, materials can be encapsulated efficiently with minimal loss. The choice of different colloidal particles allows for additional flexibility. We show that the permeability and rupture stress of the capsules can be controlled through the size of the coating particles and through post fabrication treatment by sintering or, alternatively, by further filling of the holes with smaller particles or polymers. A variety of release strategies may be feasible, either through control of their permeability for slow but sustained release, or through control of their rupture stress for shear-induced breakup. This flexibility will allow a wide range of potential applications to be explored.

Market Analysis:

It is believed that in the near future novel colloidosomes will be explored in the treatment or management of some other chronic and terminal disease conditions. Various technologies are researched and some are currently in the market. The global market for colloidosomes totalled $24 billion in 2012. The overall market is projected to be worth $25.7 billion by 2013 and $40.2 billion by 2018, a five-year compound annual growth rate (CAGR) for of 9.3% from 2013 to 2018.

International symposium and workshops

  • 13th US-Japan Symposium on Drug Delivery Systems
    December 16-20, 2015 Lahaina, Maui, Hawaii
  • 43rd Annual Meeting and Exposition of the Controlled Release Society
    July 17-20, 2016 Seattle, WA, US

List of Best International Conferences:

  1. 6th Asia-Pacific Pharma Congress July 14-16, 2016 Kuala Lumpur, Malaysia
  2. Nanomedicine Conference July 25-27, 2016 Bangkok, Thailand
  3. 8th Pharmaceutics and Novel Drug Delivery Systems Conference 
    March 07-09, 2016 Madrid, Spain
  4. Industrial Pharmacy Conference April 28-29, 2016 Dubai, UAE
  5. 4th European Pharma Congress June 13-15, 2016 Berlin, Germany
  6. American Pharma Expo June 20-22, 2016 New Orleans, USA
  7. 4th Neuropharmacology Conference September 15-17, 2016 San Antonio, USA
  8. 2nd Pharma Middle East Congress October 12-14, 2016 Dubai, UAE
  9. 4th Clinical Pharmacy Conference Oct 31 - Nov 01, 2016 Las Vegas, USA
  10. 2nd Drug Discovery Conference Oct 31-Nov 02, 2016 Istanbul, Turkey
  11. World Congress and Exhibition on Antibiotics 
    September 14-16, 2015 Las Vegas, Nevada, USA
  12. 4th International Conference and Exhibition on Immunology 
    September 28-30, 2015 Houston, Texas, USA
  13. International Conference on Lipid Science & Technology 
    November 30-December 02, 2015 San Francisco, USA
  14. 3rd International Conference on Genomics & Pharmacogenomics 
    September 21-23, 2015 San Antonio, USA
  15. 4th International Conference on Clinical Microbiology and Microbial Genomics 
    October 05-07, 2015 Philadelphia, USA
  16. ICI 2015: 17th International Conference on Immunology 
    September 25 - 26, 2015 London, United Kingdom
  17. 4th European Congress of Immunology (ECI 2015) In Vienna, Austria
  18. British Society of Allergy and Clinical Immunology Annual Meeting 2015 
    September 4- 6, 2015 Telford, United Kingdom

Relevant Societies and Associations

  • American Society for Clinical Pharmacology and Therapeutics
  • International Association for Pharmaceutical Technology
  • International Neuromodulation Society
  • Controlled Release Society
  • Inhalation Drug Delivery Association
  • International society of drug delivery sciences and technology
  • American Association of Pharmaceutical Scientists
  • Japanese Society of Drug Delivery Systems
  • Society for Neuroscience

Companies

  • Tesa Labtec GmbH
  • MonoSol Rx 
  • IntelGenx
  • BiondVax Pharmaceuticals
  • Reckitt Benckiser Pharmaceuticals
  • MidaSol Therapeutics
  • Applied Pharma Research
  • FFT Medical 
  • Cynapsus Therapeutics 

This page will be updated regularly.

This page was last updated on March 28, 2024

Conference Series Destinations